Molecules 2008, 13(8), 1817-1821; https://doi.org/10.3390/molecules13081817
Synthesis of RP 48497, an Impurity of Eszopiclone
1
Key Lab of New Drug Design and Discovery of Liaoning Province, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, P. R. China
2
Jinzhou Jiutai Pharmaceutical Co. Ltd, Jinzhou 121012, P.R. China
*
Author to whom correspondence should be addressed.
Received: 5 June 2008 / Revised: 8 August 2008 / Accepted: 12 August 2008 / Published: 22 August 2008
Abstract
RP 48497 is a photodegradation product of eszopiclone, a non-benzodiazepine sedative-hypnotic used in the treatment of insomnia. We report herein the first synthesis of RP 48497 via reduction, chlorination, and recyclization of 6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydropyrrolo[3,4-b]pyrazin-5-one (3), a key intermediate in the synthesis of eszopiclone. The structure of RP 48497 was confirmed by its 1H-NMR and MS data. The mechanism of the reduction step in the synthesis of RP 48497 was also studied and the key parameters were determined. These findings should be important for quality control purposes in the manufacture of eszopiclone. View Full-TextKeywords:
RP 48497; eszopiclone; quality control
▼
Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).
Share & Cite This Article
MDPI and ACS Style
Sharov, Y.; Zhang, L.; Du, G.-J.; Ren, J.; Cheng, M.-S. Synthesis of RP 48497, an Impurity of Eszopiclone. Molecules 2008, 13, 1817-1821.
Related Articles
Article Metrics
Comments
[Return to top]
Molecules
EISSN 1420-3049
Published by MDPI AG, Basel, Switzerland
RSS
E-Mail Table of Contents Alert